Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening
about
A CRISPR toolbox to study virus-host interactionsProgramming and reprogramming the brain: a meeting of minds in neural fate.Progress and Application of CRISPR/Cas Technology in Biological and Biomedical Investigation.RNA targeting with CRISPR-Cas13.Enhancing the Promise of Drug Repositioning through Genetics.ENCoRE: an efficient software for CRISPR screens identifies new players in extrinsic apoptosis.Dual direction CRISPR transcriptional regulation screening uncovers gene networks driving drug resistance.CRISPR Screens Uncover Genes that Regulate Target Cell Sensitivity to the Morphogen Sonic Hedgehog.Target Discovery for Precision Medicine Using High-Throughput Genome Engineering.RNA editing with CRISPR-Cas13.Pooled Lentiviral-Delivery Genetic Screens.In vivo genome editing in animals using AAV-CRISPR system: applications to translational research of human disease.High-Throughput Approaches to Pinpoint Function within the Noncoding Genome.Genome-scale activation screen identifies a lncRNA locus regulating a gene neighbourhood.Gibson Deletion: a novel application of isothermal in vitro recombination.Reprogramming cell fate with artificial transcription factors.Application of CRISPR-Cas9 Based Genome-Wide Screening Approaches to Study Cellular Signalling Mechanisms.Applications of CRISPR/Cas9 in the Mammalian Central Nervous System.Incorporation of bridged nucleic acids into CRISPR RNAs improves Cas9 endonuclease specificity.An Integrated Genome-wide CRISPRa Approach to Functionalize lncRNAs in Drug Resistance.Using Mouse Oocytes to Assess Human Gene Function During Meiosis I.NUDCD1 promotes metastasis through inducing EMT and inhibiting apoptosis in colorectal cancer.Vex-seq: high-throughput identification of the impact of genetic variation on pre-mRNA splicing efficiency.The Bicarbonate Transporter SLC4A7 Plays a Key Role in Macrophage Phagosome Acidification.Application of the CRISPR/Cas9 System to Drug Resistance in Breast Cancer.CRISPR/Cas-based customization of pooled CRISPR libraries.Unraveling of Central Nervous System Disease Mechanisms Using CRISPR Genome Manipulation.Blossom of CRISPR technologies and applications in disease treatmentMxra8 is a receptor for multiple arthritogenic alphaviruses
P2860
Q29994612-7EF645A1-1F12-41A5-AB24-DD05851E7C9AQ38648417-1AD0A567-05BA-487B-9FE3-1BE2286CC63CQ38700979-1CA07EE5-DF5B-444C-BB2D-4969F54F5626Q46092009-507FDE4A-8CF4-418F-9C47-797996474DA6Q47095277-EB8D84AA-2DF4-4073-9835-A40B23E42EE0Q47096845-1592831D-2026-4C6C-A355-AAAB84C2B5F0Q47148300-AF6FAEB9-2B2A-4029-871A-4848FFBD9DF1Q47241729-7AC0A2C2-65B1-4F8B-A880-45743C37709DQ47356354-219EF329-C838-4C42-875A-DB54B10EB097Q47410076-A6E4F83D-95ED-47DE-888E-D36093BD7C9DQ47553202-6AF60823-7B23-4B3B-A346-7E1F76A34003Q47553772-AC4C346B-1EE9-4F30-8935-FD6EAD543879Q47594697-39B97707-17A6-4CF4-BF2A-530F67EAA571Q47813986-1712562F-A35B-4A55-91EC-E7266B9E77D8Q48155943-4CB6FF96-DA74-472F-93B7-7F0596A2277EQ49497409-333CE82C-DD43-48FD-BE22-593216F62EA7Q52347926-458EDBC9-4532-4C07-8867-017219BD118DQ52429670-9AA1D76D-3119-4AFE-89FE-E027C60BE115Q52431554-1657746F-86F7-49F0-B310-4493F8AF949AQ52431745-9A7F5E76-36B5-4FCE-A14D-3AB9BDC20F00Q52715679-B263D297-F59C-4F61-811D-60380773923CQ55013675-4B2508A1-BD63-4C63-B006-0CAC02E5DE53Q55033487-45E40F81-4639-4176-A052-53516210030EQ55265444-8A34D210-EB4B-47E7-900E-7519FBD975E5Q55309854-2358D212-A76B-41A5-97D4-3DFEBB8906D8Q55424921-A6F5436A-DBE3-4353-9C58-E24A6EC67359Q55711095-D3F09665-41CB-4AE6-80E7-3486535308BDQ58120494-D138999C-310A-4D33-8FD7-E15E744F4D0CQ59059482-AAD25C9E-AFDB-4A56-BB15-86207D8C8DE0
P2860
Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
name
Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening
@ast
Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening
@en
Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening
@nl
type
label
Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening
@ast
Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening
@en
Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening
@nl
prefLabel
Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening
@ast
Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening
@en
Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening
@nl
P2093
P2860
P50
P356
P1433
P1476
Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening
@en
P2093
Feng Zhang
Mark D Brigham
Omar O Abudayyeh
Silvana Konermann
P2860
P2888
P304
P356
10.1038/NPROT.2017.016
P577
2017-03-23T00:00:00Z
P6179
1084129553